400 related articles for article (PubMed ID: 27745550)
21. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.
Azambuja D; Natkunam Y; Biasoli I; Lossos IS; Anderson MW; Morais JC; Spector N
Ann Oncol; 2012 Mar; 23(3):736-742. PubMed ID: 21602260
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma.
Karihtala K; Leivonen SK; Brück O; Karjalainen-Lindsberg ML; Mustjoki S; Pellinen T; Leppä S
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260340
[TBL] [Abstract][Full Text] [Related]
23. Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma.
Panico L; Ronconi F; Lepore M; Tenneriello V; Cantore N; Dell'Angelo AC; Ferbo U; Ferrara F
Leuk Lymphoma; 2013 Nov; 54(11):2418-25. PubMed ID: 23432688
[TBL] [Abstract][Full Text] [Related]
24. The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.
Bisheshar SK; van der Kamp MF; de Ruiter EJ; Ruiter LN; van der Vegt B; Breimer GE; Willems SM
Oral Oncol; 2022 Dec; 135():106227. PubMed ID: 36335818
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of tumor-associated macrophage infiltration in esophageal cancer: a meta-analysis.
Li J; Xie Y; Wang X; Li F; Li S; Li M; Peng H; Yang L; Liu C; Pang L; Zou H; Zhao J; Qi Y; Cao Y; Hu J
Future Oncol; 2019 Jul; 15(19):2303-2317. PubMed ID: 31237146
[No Abstract] [Full Text] [Related]
26. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.
Kamper P; Bendix K; Hamilton-Dutoit S; Honoré B; Nyengaard JR; d'Amore F
Haematologica; 2011 Feb; 96(2):269-76. PubMed ID: 21071500
[TBL] [Abstract][Full Text] [Related]
27. Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly.
Poles WA; Nishi EE; de Oliveira MB; Eugênio AIP; de Andrade TA; Campos AHFM; de Campos RR; Vassallo J; Alves AC; Scapulatempo Neto C; Paes RAP; Landman G; Zerbini MCN; Colleoni GWB
Cancer Immunol Immunother; 2019 Feb; 68(2):269-282. PubMed ID: 30430204
[TBL] [Abstract][Full Text] [Related]
28. CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast.
Jamiyan T; Kuroda H; Yamaguchi R; Abe A; Hayashi M
Virchows Arch; 2020 Dec; 477(6):767-775. PubMed ID: 32607685
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of lymphocyte/monocyte ratio in advanced Hodgkin lymphoma: correlation with International Prognostic Score and tumor associated macrophages.
Jakovic LR; Mihaljevic BS; Andjelic BM; Bogdanovic AD; Perunicic Jovanovic MD; Babic DD; Bumbasirevic VZ
Leuk Lymphoma; 2016 Aug; 57(8):1839-47. PubMed ID: 26727349
[TBL] [Abstract][Full Text] [Related]
30. CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma.
Harris JA; Jain S; Ren Q; Zarineh A; Liu C; Ibrahim S
Diagn Pathol; 2012 Jan; 7():12. PubMed ID: 22289504
[TBL] [Abstract][Full Text] [Related]
31. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer.
Lan C; Huang X; Lin S; Huang H; Cai Q; Wan T; Lu J; Liu J
Technol Cancer Res Treat; 2013 Jun; 12(3):259-67. PubMed ID: 23289476
[TBL] [Abstract][Full Text] [Related]
32. Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy.
Di Caro G; Cortese N; Castino GF; Grizzi F; Gavazzi F; Ridolfi C; Capretti G; Mineri R; Todoric J; Zerbi A; Allavena P; Mantovani A; Marchesi F
Gut; 2016 Oct; 65(10):1710-20. PubMed ID: 26156960
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature.
Zhao X; Qu J; Sun Y; Wang J; Liu X; Wang F; Zhang H; Wang W; Ma X; Gao X; Zhang S
Oncotarget; 2017 May; 8(18):30576-30586. PubMed ID: 28427165
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological correlation of tumor-associated macrophages in Ewing sarcoma.
Handl M; Hermanova M; Hotarkova S; Jarkovsky J; Mudry P; Shatokhina T; Vesela M; Sterba J; Zambo I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Mar; 162(1):54-60. PubMed ID: 29170560
[TBL] [Abstract][Full Text] [Related]
35. CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma.
Yoon DH; Koh YW; Kang HJ; Kim S; Park CS; Lee SW; Suh C; Huh J
Eur J Haematol; 2012 Apr; 88(4):292-305. PubMed ID: 22044760
[TBL] [Abstract][Full Text] [Related]
36. High CD20+ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68+ macrophages.
Panico L; Tenneriello V; Ronconi F; Lepore M; Cantore N; Dell'Angelo AC; Ferbo L; Ferrara F
Leuk Lymphoma; 2015 Jun; 56(6):1636-42. PubMed ID: 25098425
[TBL] [Abstract][Full Text] [Related]
37. Meta-Analysis of the Prognostic and Clinical Value of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
Zhang J; Chang L; Zhang X; Zhou Z; Gao Y
J Invest Surg; 2021 Mar; 34(3):297-306. PubMed ID: 31412745
[No Abstract] [Full Text] [Related]
38. The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt.
Mohamed O; El Bastawisy A; Allahlobi N; Abdellateif MS; Zekri ARN; Shaarawy S; Korany Z; Mohanad M; Bahnassy AA
Diagn Pathol; 2020 Feb; 15(1):10. PubMed ID: 32019558
[TBL] [Abstract][Full Text] [Related]
39. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.
Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y
Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392
[TBL] [Abstract][Full Text] [Related]
40. The prognostic role of tumor-associated macrophages and dendritic cells in classic Hodgkin's lymphoma.
Abdou AG; Asaad NY; Loay I; Shabaan M; Badr N
J Environ Pathol Toxicol Oncol; 2013; 32(4):289-305. PubMed ID: 24579783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
